Brief: Asahi Kasei Corp (Amendment To Disclosure)- Change In Amount Of Capital Increase In Previously Issued Notice Concerning Capital Increase Of Sub-Subsidiaries
Brief: Asahi Kasei Corp - To Buy Back Up To 2.52% Own Shares Worth 30 Billion Yen
Brief: Asahi Kasei Corp - Notice Of Establishment Of Subsidiary, Separation Between Consolidated Subsidiaries, Transfer Of Subsidiary And Transfer Of Shares In Health Care
Brief: De Nora, Asahi Kasei Sign Deal For Solutions To Produce Green Hydrogen
Brief: Asahi Kasei Corp: Notice Regarding Results Of Tender Offer For Shares Of Calliditas Therapeutics AB And Transfer Of Subsidiary
Table: Asahi Kasei -Q1 group results
Brief: Asahi Kasei Corp - To Absorb Wholly Owned Subsidiary Asahi Finance Through Simplified Merger
Deals of the day-Mergers and acquisitions
Calliditas jumps after $1.1 bln buyout by Japan's Asahi
Brief: Asahi Kasei To Acquire Calliditas Therapeutics AB
Asahi Kasei to buy Swedish drugmaker Calliditas for $1.1 billion (updated)
Deals of the day-Mergers and acquisitions
Press Digest: Wall Street Journal - May 28
Asahi Kasei to buy Swedish drugmaker Calliditas for $1.1 billion
Brief: Calliditas Board Recommends Shareholders To Accept Asahi Kasei Corp Offer
Brief: Japan's Asahi Kasei Corp: To Acquire Sweden's Calliditas Therapeutics AB For Total Equity Value Of About SEK 11.8 Billion (About JPY 174 Billion)
Press Digest: Canada - May 15
Press Digest: Canada - May 14
Table: Asahi Kasei -2023/24 group results